Therapeutic Targeting of CPT-11 Induced Diarrhea: A Case for Prophylaxis

E-ISSN： 1873-5592|14|7|777-797

ISSN： 1389-4501

Source： Current Drug Targets, Vol.14, Iss.7, 2013-06, pp. : 777-797

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fidaxomicin for treatment of clostridium difficile-associated diarrhea and its potential role for prophylaxis

By Hostler Christopher J

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 11, 2013-08 ,pp. : 1529-1536

Informa Healthcare

Access to resources Recommend Favorite

Pharmacology of Topoisomerase I Inhibitors Irinotecan (CPT-11) and Topotecan

Current Cancer Drug Targets, Vol. 2, Iss. 2, 2002-06 ,pp. : 103-123

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic potential of CPT I inhibitors: cardiac gene transcription as a target

By Rupp Heinz Zarain-Herzberg Angel

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 3, 2002-03 ,pp. : 345-356

Informa Healthcare

Access to resources Recommend Favorite

Pathophysiology and Pharmacological Targeting of Tumor-Induced Bone Disease: Current Status and Emerging Therapeutic Interventions

Current Medicinal Chemistry, Vol. 18, Iss. 11, 2011-04 ,pp. : 1584-1598

Bentham Science Publishers

Access to resources Recommend Favorite

Antitumor Therapeutic Strategies Based on the Targeting of Epidermal Growth Factor-Induced Survival Pathways

Current Drug Targets, Vol. 6, Iss. 3, 2005-05 ,pp. : 289-300

Bentham Science Publishers

Access to resources Recommend Favorite